OBSERVATIONAL STUDY OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS
A NON-INTERVENTIONAL, OBSERVATIONAL STUDY OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS
Study Type
OBSERVATIONAL
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
To study the incidence, risk factors, clinical presentation, diagnosis and prognostic factors of infectious complications in cancer patients
To study the incidence, risk factors, clinical presentation, diagnosis and prognostic factors of infectious complications in cancer patients
Time frame: 3 years
incidence
To determine the overall incidence of different infections, including bacterial, fungal and viral infections in cancer patients receiving chemotherapy and / or hematopoietic stem cell transplantation. * To describe the natural history of such infections in cancer patients. * To monitor the adherence of Myeloma institute for research and therapy(MIRT) health care workers to the MIRT standard operational procedures (SOPs) * To identify risk factors for the development of specific infections. * To validate surrogate markers as early diagnostic tools for various infections.
Time frame: 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.